Literature DB >> 25425255

Oral ketamine analgesia in chronic pain and problematic rise in blood pressure.

Oliver van Hecke1, Bruce Guthrie2.   

Abstract

Hospitals and specialists in the UK are increasingly prescribing and dispensing off-license drugs such as ketamine which are not routinely included in the prescribing record of the general practitioner (GP). We present the case of a 67-year-old woman who developed an episode of uncontrolled raised blood pressure (BP) (224/124 mm Hg) following hospital introduction of oral ketamine for chronic pain. This raised BP was not followed up, and she was then found to be persistently hypertensive in the community some months later. No obvious cause for the patient's increase in BP could be identified. Only on reduction of the ketamine dose and introduction of additional antihypertensive medication, did her BP normalise. We postulate that long-term ketamine use may have been associated with this unexpected and persistent rise in BP. Clinicians should monitor BP closely during ketamine therapy and be wary of new hypertension associated with its long-term use. Further research is needed on the long-term effects of ketamine on BP. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25425255      PMCID: PMC4248103          DOI: 10.1136/bcr-2014-207836

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Ketamine: new uses for an old drug?

Authors:  K Hirota; D G Lambert
Journal:  Br J Anaesth       Date:  2011-08       Impact factor: 9.166

Review 2.  Ketamine for chronic pain: risks and benefits.

Authors:  Marieke Niesters; Christian Martini; Albert Dahan
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

3.  Low dose ketamine as an analgesic adjuvant in difficult pain syndromes: a strategy for conversion from parenteral to oral ketamine.

Authors:  Edward J Fitzgibbon; Pippa Hall; Cori Schroder; John Seely; Raymond Viola
Journal:  J Pain Symptom Manage       Date:  2002-02       Impact factor: 3.612

4.  Ketamine abusers presenting to the emergency department: a case series.

Authors:  A L Weiner; L Vieira; C A McKay; M J Bayer
Journal:  J Emerg Med       Date:  2000-05       Impact factor: 1.484

Review 5.  Ketamine for chronic noncancer pain: concerns regarding toxicity.

Authors:  Rae F Bell
Journal:  Curr Opin Support Palliat Care       Date:  2012-06       Impact factor: 2.302

6.  Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1.

Authors:  Marnix J Sigtermans; Jacobus J van Hilten; Martin C R Bauer; Sesmu M Arbous; Johan Marinus; Elise Y Sarton; Albert Dahan
Journal:  Pain       Date:  2009-07-14       Impact factor: 6.961

7.  Side effects of ketamine in the long-term treatment of neuropathic pain.

Authors:  Petr Cvrcek
Journal:  Pain Med       Date:  2008-03       Impact factor: 3.750

Review 8.  Use of oral ketamine in chronic pain management: a review.

Authors:  Maren I Blonk; Brigitte G Koder; Patricia M L A van den Bemt; Frank J P M Huygen
Journal:  Eur J Pain       Date:  2009-10-29       Impact factor: 3.931

Review 9.  Ketamine in pain management.

Authors:  Jan Persson
Journal:  CNS Neurosci Ther       Date:  2013-05-11       Impact factor: 5.243

10.  Ketamine infusions for treatment resistant depression: a series of 28 patients treated weekly or twice weekly in an ECT clinic.

Authors:  Peter R Diamond; Andrew D Farmery; Stephanie Atkinson; Jag Haldar; Nicola Williams; Phil J Cowen; John R Geddes; Rupert McShane
Journal:  J Psychopharmacol       Date:  2014-04-03       Impact factor: 4.153

View more
  2 in total

1.  Ketamine for pain management.

Authors:  Rae Frances Bell; Eija Anneli Kalso
Journal:  Pain Rep       Date:  2018-08-09

2.  Ketamine-mediated afferent-specific presynaptic transmission blocks in low-threshold and sex-specific subpopulation of myelinated Ah-type baroreceptor neurons of rats.

Authors:  Lu-Qi Wang; Sheng-Zhi Liu; Xin Wen; Di Wu; Lei Yin; Yao Fan; Ye Wang; Wei-Ran Chen; Pei Chen; Yang Liu; Xiao-Long Lu; Hong-Li Sun; Weinian Shou; Guo-Fen Qiao; Bai-Yan Li
Journal:  Oncotarget       Date:  2015-12-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.